TMEM160 and gastric adenocarcinoma: Survival analysis demonstrated that high TMEM160 expression was associated with significantly reduced overall survival (median OS = 26 vs undefined months, p < 0.0001; Fig. 8F), a finding independently validated in the TCGA STAD cohort(Supplementary Fig. 6D, E).